Multisession tDCS combined with intrastimulation training improves emotion recognition in adolescents with autism spectrum disorder
Previous studies indicate that transcranial direct current stimulation (tDCS) is a promising emerging treatment option for autism spectrum disorder (ASD) and its efficacy could be augmented using concurrent training. However, no intrastimulation social cognition training for ASD has been developed so far. The objective of this two-armed, double-blind, randomized, sham-controlled clinical trial is to investigate the effects of tDCS combined with a newly developed intrastimulation social cognition training on adolescents with ASD. Twenty-two male adolescents with ASD were randomly assigned to receive 10 sessions of either anodal or sham tDCS at F3/right supraorbital region together with online intrastimulation training comprising basic and complex emotion recognition tasks. Using baseline magnetic resonance imaging data, individual electric field distributions were simulated, and brain activation patterns of the training tasks were analyzed. Additionally, questionnaires were administered at baseline and following the intervention. Compared to sham tDCS, anodal tDCS significantly improved dynamic emotion recognition over the course of the sessions. This task also showed the highest activations in face processing regions. Moreover, the improvement was associated with electric field density at the medial prefrontal cortex and social awareness in exploratory analyses. Both groups showed high tolerability and acceptability of tDCS, and significant improvement in overall ASD symptoms. Taken together, multisession tDCS improved dynamic emotion recognition in adolescents with ASD using a task that activates brain regions associated with the social brain network. The variability in the electric field might diminish tDCS effects and future studies should investigate individualized approaches.
Authors
- Stefan T. Radev (ORCID: https://orcid.org/0000-0002-6702-9559)
- Gabriel Amador de Lara
- Paul L. Plener (ORCID: https://orcid.org/0000-0003-4333-1494)
- Rupert R. Lanzenberger (ORCID: https://orcid.org/0000-0003-4641-9539)
- Manfred Klöbl (ORCID: https://orcid.org/0000-0003-2107-8803)
- Luise Poustka (ORCID: https://orcid.org/0000-0002-7738-4394)
- Lilian Konicar (ORCID: https://orcid.org/0000-0002-0822-061X)
- Karin Prillinger (ORCID: https://orcid.org/0000-0001-9835-1850)
Institutions
- Rensselaer Polytechnic Institute (US)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Comprehensive Cancer Center Vienna (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Neurotherapeutics
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1016/j.neurot.2024.e00460
- Citations
- 10
- Primary Topic
- Autism Spectrum Disorder Research
- Type
- article
- Field-Weighted Citation Impact
- 3.43
Funders
- Austrian Science Fund
- Universität Wien
- Medizinische Universität Wien